ProShare Advisors LLC Sells 1,544 Shares of Humana Inc. (NYSE:HUM)

ProShare Advisors LLC trimmed its position in Humana Inc. (NYSE:HUM) by 7.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,418 shares of the insurance provider’s stock after selling 1,544 shares during the quarter. ProShare Advisors LLC’s holdings in Humana were worth $6,882,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Quest Partners LLC purchased a new position in Humana during the 4th quarter valued at about $128,000. Cambridge Investment Research Advisors Inc. increased its holdings in Humana by 12.3% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 10,323 shares of the insurance provider’s stock valued at $4,726,000 after buying an additional 1,127 shares during the period. Advisory Services Network LLC raised its stake in Humana by 271.8% in the fourth quarter. Advisory Services Network LLC now owns 3,963 shares of the insurance provider’s stock worth $1,815,000 after buying an additional 2,897 shares in the last quarter. Parallel Advisors LLC lifted its holdings in Humana by 8.9% during the fourth quarter. Parallel Advisors LLC now owns 1,980 shares of the insurance provider’s stock worth $906,000 after buying an additional 161 shares during the period. Finally, Edmond DE Rothschild Holding S.A. boosted its position in Humana by 1,168.0% during the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 317 shares of the insurance provider’s stock valued at $145,000 after acquiring an additional 292 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Trading Down 0.2 %

HUM stock opened at $312.29 on Wednesday. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The firm has a market cap of $37.63 billion, a P/E ratio of 19.45, a PEG ratio of 2.56 and a beta of 0.50. The company’s 50-day simple moving average is $354.61 and its 200-day simple moving average is $345.12.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. Humana’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $8.94 earnings per share. As a group, equities analysts forecast that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.13%. Humana’s payout ratio is currently 22.04%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent research reports. Piper Sandler assumed coverage on Humana in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price target for the company. Truist Financial boosted their target price on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a report on Monday, July 15th. JPMorgan Chase & Co. raised their price target on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. TD Cowen boosted their price objective on shares of Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Finally, Oppenheimer raised their target price on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. Thirteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average price target of $398.70.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.